- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02328248
Usage of Biological Patch Versus Plastic in the Laparoscopic Repair of Hiatal Hernias
December 26, 2014 updated by: Xiaonan Liu, Xijing Hospital of Digestive Diseases
Randomized Control Trial (RCT) That the Usage With Biological Patch Versus Plastic in the Laparoscopic Repair
The purpose of this study is to observe the effective and safety in the laparoscopic repair of hiatal hernia using biological patch versus plastic.
Study Overview
Detailed Description
observation indicator:
- incidence rate of complications,
- postoperative hospital stay
- readmission rate in 1st month after operation
- recurrence rate after operation
- hospitalization costs
- Self-evaluation of gastroesophageal reflux symptoms and quality of life(QOL) in 6th-month, 1st-year,2nd-year,3rd-year,4th-year and 5th-year after operation
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Hiatal hernia
- Consistent with operation indications throughout the guideline of hiatal hernia by the Chinese Medical Association in 2003
- randomly select patch agreed by patients and family members
Exclusion Criteria:
- Poor general condition
- severe organ dysfunction
- No-tolerate anesthesia
- No-suitable for operation
- Emergency operation needed
- Serious adverse events appeared during the operation
- Sever intraperitoneal adhesion existed
- glucocorticoid with long-term use
- immunocompromised patients
- spirit disease patients
- automatically exit
- women who pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Biological patch
Use biological patch (Biodesign Surgisis Tissue Graft from Cook Biotech Incorporated) to repair hiatal hernia laparoscopically
|
Use biological patch as opposed to plastic patch to repair hiatal hernia laparoscopically
|
|
PLACEBO_COMPARATOR: Plastic patch
Use plastic patch (Parietex Composite from Sofradim Production) to repair hiatal hernia laparoscopically
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incidence of complications in all case
Time Frame: five years
|
five years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (ANTICIPATED)
July 1, 2016
Study Completion (ANTICIPATED)
December 1, 2016
Study Registration Dates
First Submitted
November 28, 2014
First Submitted That Met QC Criteria
December 26, 2014
First Posted (ESTIMATE)
December 31, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
December 31, 2014
Last Update Submitted That Met QC Criteria
December 26, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HH-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiatal Hernia
-
University Hospital, BordeauxRecruiting
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Foregut Research FoundationRecruitingParaesophageal Hernia | Large Hiatal HerniaUnited States
-
Prof Urs ZinggEnrolling by invitationHiatal Hernia Large
-
Oulu University HospitalCentral Finland Hospital DistrictRecruitingRecurrence | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Paraesophageal HerniaFinland
-
University of WashingtonSynovis Surgical InnovationsCompletedHiatal HerniaUnited States
-
Washington University School of MedicineMusculoskeletal Transplant FoundationCompleted
-
Zagazig UniversityCompleted
-
Beijing Friendship HospitalCompleted
-
Paracelsus Medical UniversityMedical University of Vienna; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaboratorsNot yet recruiting
Clinical Trials on Biological patch
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Tanta UniversityCompletedEpidural | Postdural Puncture Headache | Racz Catheter | Plasma Rich Fibrin | Epidural Blood PatchEgypt
-
En Chu Kong HospitalCompleted
-
DurectPfizerCompletedChronic Low Back PainUnited States
-
GE HealthcareCompleted
-
University of ZurichCompletedAllergic RhinoconjunctivitisSwitzerland
-
Baylor College of MedicineRecruiting
-
Fayoum UniversityNot yet recruitingImpacted Third Molar Tooth
-
Poitiers University HospitalNot yet recruitingNicotine Replacement Therapy | Healthcare Professionals | Tobacco Craving | Tabacco CessationFrance